Brandon Rockwell is Chief Operating Officer at PAI Pharma where he is responsible for PAI’s Growth Strategy. At PAI, he has responsibility for various functions in the organization including R&D, Regulatory, Business Development, Project / Alliance Management and Operations.
Brandon has over 15 years of Pharma experience and has held various areas of responsibilities in generic and branded organizations primarily focused on portfolio, growth and M&A. Prior to PAI, Brandon was at Endo Pharmaceuticals where he was on the Executive Leadership Team and had various roles, culminating in Senior Vice President of Business Development and Strategy for the branded, sterile and generics divisions. Prior to Endo, he held a senior leadership role at Par Pharmaceutical with responsibilities over Business Development, Project Management and Portfolio Management.
Brandon holds MBA from New Jersey Institute of Technology and a Bachelor of Science from Grove City College.